Scientists at UT Southwestern Medical Center in the United States recently revealed that bacteria present in the intestine play a crucial role in regulating the body’s immune system. The discovery points to the targeting of vitamin A through a previously unknown cellular network. The preclinical findings, published in the journal Cell Host & Microbe, could transform understanding of how immune development is affected, highlighting nutrient pathways as potential targets for new therapeutic interventions.

“We’ve known for years that both gut microbes and vitamin A are important for building a healthy immune system,” said Tarun Srinivasan, Ph.D., first author of the study and medical student at UT Southwestern. “What we didn’t understand was how these two factors were connected. This study identifies the pathway that links them.”

Co-corresponding authors of the research are Lora Hooper, Ph.D., chair and professor of immunology, and Andrew Koh, MD, professor of pediatrics and chief of the Division of Pediatric Hematology and Oncology. Both are members of the Harold C. Simmons Comprehensive Oncology Center.

Full coverage: Latest News (EN)

The immune system relies on signals derived from vitamin A to guide the development of T cells, a type of immune cell critical in protecting the body against infections. While the importance of vitamin A and the gut microbiome for immune development has long been known, exactly how these elements interact has remained a mystery until now.

How microorganisms transport vitamin A

UTSW researchers discovered that gut bacteria in mice initiate a gradual transfer of vitamin A between cells. This process begins in the lining of the intestine, where microorganisms stimulate the production of a protein that binds to vitamin A, known as serum amyloid A (SAA). The SAA protein transports vitamin A to immune cells in the intestine, which then take it to nearby lymph nodes and transmit vitamin A-derived signals to developing T cells.

When intestinal bacteria are eliminated, this vitamin A distribution mechanism is practically paralyzed. This prevents developing T cells from maturing properly or migrating to the intestine. Because these phases are vital for the formation of a functional immune defense, disruptions in this pathway can compromise the body’s ability to fight infection or maintain its usual immune balance.

Scientists have also shown that this pathway intensifies during early childhood – a crucial period when the immune system is being programmed. This suggests that disruptions at this stage could have long-term consequences.

In summary, this work demonstrates that intestinal microorganisms are not just passive inhabitants; they actively control how an essential nutritional signal reaches the cells that make up the immune system.

Impacts on childhood and future clinical use

The study authors said these findings may help explain how exposure to antibiotics early in life affects immune development. Because the newly identified pathway depends on signals from the gut microbiota, changes in the microbiome could interfere with the transmission of vitamin A signals to developing immune cells. Understanding this process may elucidate the relationship between microbiome disruption at early ages and increased risk of infections, inflammatory conditions, or poor immune regulation in adulthood.

“One of the great mysteries in the field has been how the gut microbiome communicates with the developing immune system,” Hooper said. “Our study shows that vitamin A is a key part of this communication. It’s exciting because it reveals how gut microorganisms and dietary nutrients collaborate to help build a healthy immune system from an early age.”

The revelations indicate that gut microorganisms do more than simply stimulate immune cells. They also control the distribution of an essential nutrient-derived developmental signal throughout the immune system.

This research suggests that immune development may not only depend on the availability of nutrients like vitamin A, but also on the body’s ability to deliver these nutrients to the correct immune cells at the right time.

“These findings point to vitamin A signaling as a potentially viable way to modulate immune responses,” Koh highlighted. “From a translational perspective, this raises the possibility that careful modulation of this pathway could one day help improve the balance between efficacy and toxicity in cancer immunotherapy.”